Skip to main content

Table 3 Insulin-resistance indices in subjects with cardiac syndrome X vs. coronary artery disease (status without known diabetes mellitus)

From: Post-challenge insulin concentration is useful for differentiating between coronary artery disease and cardiac syndrome X in subjects without known diabetes mellitus

 

CSX

(N = 92)

CAD

(N = 145)

p

HbA1C (%)

5.8 (5.6, 6.1)

6.0 (5.7, 6.4)

0.002

Fasting glucose (mg/dl)

93 (87, 100)

94 (89, 102)

0.115

OGTT 30 min glucose (mg/dl)

163 (146, 184)

165 (149, 188)

0.204

OGTT 2 h glucose (mg/dl)

127 (106, 155)

143 (114, 186)

0.004

Fasting insulin (µIU/ml)

8.3 (5.1, 13.8)

9.4 (6.0, 15.7)

0.317

OGTT 30 min insulin (µIU/ml)

65.0 (38.9, 99.9)

61.4 (39.1, 94.7)

0.817

OGTT 2 h insulin (µIU/ml)

47.3 (34.6, 75.9)

68.3 (40.1, 116.7)

0.002

HOMA-IR (mg/dl × µIU/ml)

2.0 (1.2, 3.3)

2.2 (1.3, 3.8)

0.231

OGTT derived insulin-sensitivity index, Matsuda (mM × µIU/ml)−1

87.1 (53.7, 143.0)

68.9 (46.8, 117.7)

0.054

  1. Non-normally distributed data are expressed as median (interquartile range, 25th percentile to 75th percentile)
  2. HbA 1C glycated hemoglobin, OGTT oral glucose tolerance test